Tanner Pharmaceuticals Partners with the Chao Center to Commercialize Cycloserine in Latin America

Published: Aug 17, 2010

CHARLOTTE, N.C. & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Tanner Pharmaceuticals Inc. ("Tanner") announced Tuesday (Aug. 17) that it has entered into an exclusive agreement with the Chao Center for the rights to distribute Cycloserine, a drug to treat multidrug-resistant tuberculosis, in the Latin American market.

Back to news